ArticleFrontiers in immunology2022

CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation.

Isabel Martínez-Romera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.